Scientists have developed a cancer vaccine that stopped three different types of aggressive tumors from growing in mice.

Ingelheim, Germany / Ridgefield, Connecticut, U.S.Data from the Phase Ib Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients ...

The opening-night gala for the Metropolitan Opera’s new season may be the last place you would expect to find yet another ...

All that feed corn and all those soybeans—and those nearly 25 million hogs—produce a lot of nitrate. It’s making Iowans sick ...

Boehringer Ingelheim’s zongertinib demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC: Ingelheim, Germany Monday, Oc ...

The Simpsons Hit & Run Gets Eye-Catching Futurama Mod — And Even The Original Game's Lead Designer is Impressed An impressive ...

EVERSANA  to provide integrated commercialization services, enhancing launch readiness and market entry for differentiated ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Ingelheim, Germany / Ridgefield, Connecticut, U.S. Data from the Phase Ib Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC were presented ...

Johnson & Johnson today announced promising new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous (SC) amivantamab monotherapy in patients with human ...

Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 ...